Have a feature idea you'd love to see implemented?
Let us know!
JSPR Jasper Therapeutics Inc
Price (delayed)
$15.1
Market cap
$228.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.08
Enterprise value
$123.17M
Highlights
The EPS is up by 49% year-on-year and by 9% since the previous quarter
JSPR's debt is down by 28% YoY and by 9% QoQ
Jasper Therapeutics's net income has decreased by 13% YoY but it has increased by 2.3% QoQ
JSPR's quick ratio is down by 20% since the previous quarter and by 18% year-on-year
JSPR's equity is down by 11% since the previous quarter and by 9% year-on-year
Key stats
What are the main financial stats of JSPR
Market
Valuations
Earnings
Shares outstanding
15.11M
Market cap
$228.09M
Enterprise value
$123.17M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.27
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$62.44M
EBITDA
-$60.84M
Free cash flow
-$56.29M
Per share
Balance sheet
Liquidity
EPS
-$5.08
Free cash flow per share
-$3.76
Book value per share
$6.65
Revenue per share
$0
TBVPS
$7.6
Total assets
$113.93M
Total liabilities
$13.62M
Debt
$2.32M
Equity
$100.31M
Working capital
$98.61M
Debt to equity
0.02
Current ratio
10.79
Quick ratio
10.65
Net debt/EBITDA
1.72
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-56.1%
Return on equity
-64.7%
Return on invested capital
N/A
Return on capital employed
-60.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
JSPR stock price
How has the Jasper Therapeutics stock price performed over time
Intraday
-4.91%
1 week
-11.23%
1 month
-21.76%
1 year
62.37%
YTD
91.38%
QTD
-19.72%
Financial performance
How have Jasper Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$68.15M
Net income
-$62.44M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 17% year-on-year but it has increased by 2.6% since the previous quarter
Jasper Therapeutics's net income has decreased by 13% YoY but it has increased by 2.3% QoQ
Growth
What is Jasper Therapeutics's growth rate over time
Valuation
What is Jasper Therapeutics stock price valuation
P/E
N/A
P/B
2.27
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 49% year-on-year and by 9% since the previous quarter
JSPR's equity is down by 11% since the previous quarter and by 9% year-on-year
The price to book (P/B) is 3.9% higher than the last 4 quarters average of 2.3
Efficiency
How efficient is Jasper Therapeutics business performance
The company's return on equity rose by 7% YoY
The company's return on assets rose by 6% YoY
Dividends
What is JSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for JSPR.
Financial health
How did Jasper Therapeutics financials performed over time
JSPR's quick ratio is down by 20% since the previous quarter and by 18% year-on-year
The current ratio has decreased by 20% from the previous quarter and by 18% YoY
JSPR's debt is 98% lower than its equity
The debt to equity has declined by 33% year-on-year
JSPR's debt is down by 28% YoY and by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.